Home
Reels
Grupuri
Pagini
Arata mai mult
Grupuri Pagini Events Blogs Offers Jobs Courses Movies Merits
Conecteaza-te Inscrie-te
Theme Switcher
Night Mode
Sponsor
Blinatumomab (BLINCYTO) Prescribing Information | Hong Kong Dengyue Medicine
BLINCYTO® is the world’s first approved BiTE® immuno-oncology therapy, targeting the CD19 surface antigen on B cells. BiTE® molecules help the immune system detect and target malignant cells by bringing T cells—a type of white blood cell capable of killing cells recognized as threats—into contact with cancer cells. By positioning T cells near cancer cells, they can...
0 Commentarii ·0 Distribuiri ·100 Views ·0 previzualizare
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Sponsor
Upgrade to Pro
Alege planul care ți se potrivește
Upgrade
Sponsor
Sponsor